Assessing the impact of multi-compartment compliance aids on clinical outcomes in the elderly: A pilot study

International Journal of Clinical Pharmacy

Volumn 36, Issue 1, 2014, Pages 98-104

  Mosca, Carolina ^a   Castel Branco, Margarida M ^a   Ribeiro Rama, Ana C ^a   Caramona, Margarida M ^a   Fernandez Llimos, Fernando ^b   Figueiredo, Isabel V ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Aged; Community pharmacy; Elderly; Medication adherence; Pharmaceutical services; Portugal

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; COUNSELING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MORISKY SELF REPORTED SCALE; MULTICOMPARTMENT COMPLIANCE AIDS; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACY; PILOT STUDY; PORTUGAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SELF CONCEPT; SYSTOLIC BLOOD PRESSURE; AGING; ANALYSIS; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; DRUG PACKAGING; PSYCHOLOGY; SELF REPORT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CASE-CONTROL STUDIES; COMMUNITY PHARMACY SERVICES; DRUG PACKAGING; FEMALE; HUMANS; LIPIDS; MALE; MEDICATION ADHERENCE; PILOT PROJECTS; PROSPECTIVE STUDIES; SELF REPORT; TREATMENT OUTCOME;

EID: 84899491575     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-013-9852-2     Document Type: Article

References (36)

1. World Health Organization. Active ageing: a policy framework. Geneva: WHO; 2002. Available: http://whqlibdoc.who.int/hq/2002/who-nmh-nph-02.8.pdf. Accessed 30 July 2013.
2. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, Meinow B, Fratiglioni L. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430-9.
3. Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, Franchi C, De Vittorio L, Marengoni A, Corrao S, Iorio A, Marcucci M, Mannucci PM. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol. 2011;67(5):507-19.
4. Hanlon JT, Lindblad CI, Hajjar ER, McCarthy TC. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother. 2003;1(1):38-43. (Pubitemid 40410985)
5. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269(21):2779-81. (Pubitemid 23154254)
6. Fraser S. Concordance, compliance, preference or adherence. Patient Prefer Adherence. 2010;4:95-6.
7. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868-79. (Pubitemid 35425073)
8. DeMaria AN. Adherence, compliance, concordance, or the lack thereof. J Am Coll Cardiol. 2012;59(12):1120-1.
9. World Health Organization. Adherence to longterm therapies. Evidence for action. Geneva: WHO; 2003. Available: http://whqlibdoc.who.int/publications/ 2003/9241545992.pdf. Accessed 30 July 2013.
10. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51(6):615-22. (Pubitemid 32862751)
11. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005;39(2):319-28. (Pubitemid 40165223)
12. Saez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI. Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients. Age Ageing. 2013;42(4):442-9.
13. Nunney JM, Raynor DK. How are multi-compartment compliance aids used in primary care? Pharm J. 2001;48(5):784-9. (Pubitemid 33130726)
14. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011;7(9):CD005025.
15. Zedler BK, Kakad P, Colilla S, Murrelle L, Shah NR. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33(1):62-73.
16. Raynor DK, Nunney JM. Medicine compliance aids are partial solution, not panacea. BMJ. 2002;324(7349):1338. (Pubitemid 34606786)
17. National Institute for Health and Clinical Excellence. Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. Manchester: NICE; 2009. Available: http://www.nice.org.uk/ nicemedia/pdf/CG76FullGuideline.pdf. Accessed 30 July 2013.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. (Pubitemid 37430158)
19. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
20. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S11-61.
21. Portuguese General Health Directorate. Guidelines on diabetes mellitus diagnose and classification (002/2011). Lisbon; 2011. Available: http://www.dgs.pt/ms/7/paginaRegisto.aspx?back=1&id=19925. Accessed 30 July 2013.
22. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. (Pubitemid 16125389)
23. Fitzmaurice G, Laird N, Ware J. Applied longitudinal analysis. Hoboken: Wiley; 2004. ISBN 0-471-21487-6.
24. Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Commun Stat Simul Comput. 1994;23(4):939-51.
25. Lecouturier J, Cunningham B, Campbell D, Copeland R. Medication compliance aids: a qualitative study of users' views. Br J Gen Pract. 2011;61(583):93-100.
26. Nunney J, Raynor DK, Knapp P, Closs SJ. How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids? A qualitative study using grounded theory. Drugs Aging. 2011;28(5):403-14.
27. DiIorio C, Yeager K, Shafer PO, Letz R, Henry T, Schomer DL, McCarty F. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155-62.
28. Guillausseau PJ. Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration. Treat Endocrinol. 2005;4(3):167-75.
29. McDonald MV, Peng TR, Sridharan S, Foust JB, Kogan P, Pezzin LE, Feldman PH. Automating the medication regimen complexity index. J Am Med Inform Assoc. 2013;20(3):499-505.
30. George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369-76. (Pubitemid 39100186)
31. Melchiors AC, Correr CJ, Fernandez-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210-8. (Pubitemid 350304940)
32. Stange D, Kriston L, Langebrake C, Cameron LK, Wollacott JD, Baehr M, Dartsch DC. Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI-D). J Eval Clin Pract. 2012;18(3):515-22.
33. Landsberger HA. Interaction process analysis of the mediation of labor-management disputes. J Abnorm Psychol. 1955;51(3):552-8.
34. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770-81. (Pubitemid 350044338)
35. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569-82. (Pubitemid 47479786)
36. Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sintek CD, Dombrowski R, Geraets DR, Amato M. Types of interventions made by clinical pharmacists in the IMPROVE study. Impact of managed pharmaceutical care on resource utilization and outcomes in veterans affairs medical centers. Pharmacotherapy. 2000;20(4):429-35.